Small-Animal Spect/Ct Imaging with 99Mtc-Hynic-h10f Detects Her2 Expression in Mice Bearing Human Breast Cancers

Yue Wu,Liqiang Li,Chengyan Dong,Fan Wang

2016-01-01

Abstract:1162 Objectives Breast cancer is the most frequent cancer and the second-leading cause of cancer death for women in the United States. Human epidermal growth factor receptor 2 (HER2) overexpression is highly associated with the metastasis and malignancy of breast cancer. To detect HER2 expression of tumors in vivo, we developed an agent specifically binds to HER2, 99mTc-labeled H10F, and investigated its capacity for detection of HER2 expression during Herceptin therapy in breast tumors with quantification of SPECT/CT imaging. Methods The HER2-targeted peptide H10F was synthesized by solid phase peptide synthesis and conjugated with a bifunctional chelator HYNIC. The HER2 binding specificity of H10F was verified by immunofluorescence staining of HER2-positive SK-BR3 and HER2-negative MDA-MB-231 cells. HYNIC-H10F was labeled with 99mTc. Then biodistribution and tumor imaging were performed in mice bearing SK-BR3 and MDA-MB-231 human breast cancers, respectively. Results H10F and HYNIC-H10F were characterized by HPLC analysis and mass spectrometry to confirm the structure and purity. Immunofluorescence staining demonstrated FITC-H10F can effectively distinguish different expression of HER2 in SK-BR3 and MDA-MB-231 cells. 99mTc-labeled H10F was prepared with high radiochemical purity (>95%). SPECT/CT imaging showed that the SK-BR3 tumors were clearly visualized (2.46 ± 0.28 %ID/g at 30 min p.i.) while the signals in HER2-negetive MDA-MB-231 tumors were much lower (1.64 ± 0.30 %ID/g at 30 min p.i.). Tumor uptake was higher than all organs except the kidneys at 30 min p.i. Biodistribution studies showed more significant difference in T/NT ratios (4.40 ± 0.29 vs. 2.02 ± 0.47, p Conclusions FITC-H10F specifically binds to HER2 positive tumor cells and 99mTc-HYNIC-H10F accumulates in corresponding tumor model, leading to a distinguished tumor imaging effect of HER2 expression. It suggests that 99mTc-labeled-H10F could be an effective probe for detection of HER2 expression and evaluation of Herceptin involved therapies.